Alternatives to PhosPrint

BICO Group is a global leader in life science solutions, enabling the bioprinting and analysis of cells, tissues, and organs.

Pioneering 3D bioprinting company developing functional human tissue models for drug discovery and regenerative medicine

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Seevix Material Sciences develops and produces SVX, a proprietary spider silk protein, for various industrial and medical applications.

Biotech company developing targeted regenerative therapeutics using a proprietary protein engineering platform for tissue repair.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Clinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Nano Dimension provides intelligent machines for the fabrication of Additively Manufactured Electronics (AME).

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Leveraging the adaptive immune system to diagnose and treat disease.

North American subsidiary of CTIBIOTECH, a leader in 3D bioprinting of human tissue.

AI-powered platform for 3D-printed patient-specific surgical instruments at scale.

Pioneering bio-engineered skin grafts for severe burns and chronic wounds.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

AI-powered platform for understanding disease biology and accelerating drug discovery.

A global oncology company developing and commercializing innovative cancer treatments.

AI-guided drug discovery platform for tissue-targeted medicines.

CollPlant Biotechnologies develops and commercializes medical products for regenerative medicine and aesthetics based on its plant-derived recombinant human collagen (rhCollagen) technology.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

AI-powered platform for real-time organ physiology to accelerate human-relevant drug discovery.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Mapping cell-cell communication at scale in human tissue.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Intero Biosystems develops human intestinal organoid platforms for drug discovery, aiming to improve preclinical testing and reduce animal reliance.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Biotech company developing novel therapeutics for regenerative medicine and oncology.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

AI-powered drug discovery and development platform for biologics.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Develops and commercializes recombinant human collagen fibers for tissue engineering and bioprinting.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotech company developing next-generation gene writing tools for advanced therapies.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Advance every cancer decision.

Biotechnology company developing novel immunotherapies for cancer.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.